Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-021279

Chief Business Officer sold 27,154 shares at an average $20.08 ($545,162)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Business Officer 2017-08-28 Sale −23,154 $20.09 $465,162 110,893 D: show line 1 in the form
Kulkarni Samarth Chief Business Officer 2017-08-30 Sale −4,000 $20.00 $80,000 106,893 D: show line 2 in the form
Open-market sales · 27,154 sh · avg $20.08 · $545,162
Loading xslF345X03/doc4.xml…